MedTrace Logo

Effect of Prebiotic Sodas on Postprandial Levels of GLP-1, PYY, Transit Time and Satiety Levels: A Pilot Study

NCT07362563 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 15

Last updated 2026-01-28

No results posted yet for this study

Summary

The main objective of this study is to evaluate the acute effects of prebiotic sodas on postprandial levels of glucagon-like peptide-1 (GLP-1), peptide YY (PYY), gastric emptying, and satiety levels in healthy adults.

Conditions

  • Satiety in Healthy Volunteers

Interventions

OTHER

Control Soda

Participants will consume one 12 oz can of a control soda that contains 0 g dietary fiber and 4 g total sugar.

OTHER

Prebiotic Soda - Shelf Stable

Participants will consume one 12 oz can of a shelf stable prebiotic soda that contains 6 g dietary fiber and 4 g total sugar.

OTHER

Prebiotic Soda - Refrigerated

Participants will consume one 12 oz can of a shelf stable prebiotic soda that contains 9 g dietary fiber and 4 g total sugar.

OTHER

Prebiotic Soda - Shelf Stable + Functional Ingredient

Participants will consume one 12 oz can of a shelf stable prebiotic soda that contains 6 g dietary fiber, 4 g total sugar, and an added functional ingredient.

Sponsors & Collaborators

  • INQUIS Clinical Research

    collaborator INDUSTRY

  • Olipop, PBC

    lead INDUSTRY

Principal Investigators

  • Janice Campbell · INQUIS Clinical Research

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
SINGLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2026-01-31
Primary Completion
2026-05-31
Completion
2026-05-31

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07362563 on ClinicalTrials.gov